- healthcare
- Quality & Compliance
- representative
Global Medical Device Portfolio Compliance & EU MDR / FDA Regulation Updates
A global medical technology manufacturer with a portfolio of 450 class II and class III cardiovascular and orthopedic devices marketed across 35 countries.
Runs onParivart- regulatory change detection and impact analysis time cut
- 6 weeksregulatory change detection and impact analysis time cut
- reduced regulatory consulting and contractor spend
- $480,000reduced regulatory consulting and contractor spend
How the work runs
The pressure that made this worth automating, the steps the system runs, and what came out the other side.
Pressure & Trigger Points
- Regulatory affairs teams monitored dozens of global health authority websites manually (FDA, EMA, NMPA, PMDA), missing critical guidance updates.
- A new EU MDR clinical evaluation guidance revision required updates to 180 device Technical Files, but identifying affected product families took 6 weeks.
- Delayed submission of updated regulatory filings risked product market withdrawal in key European territories.
The run · 5 operational steps
Click any step to inspect telemetry signals, model reasoning, and governance gates.
scroll →
Global Health Authority Feed Ingestion
Parivart ingests and indexes real time regulatory notices, guidance documents, and safety bulletins from over 40 global regulatory agencies.
Real-time operational telemetry & queue
MCP grounded vector inference
Policy constrained with audit write-back
Verified Business Outcomes
- Regulatory change detection and impact analysis time cut from 6 weeks to 2 hours.
- Zero product market withdrawals or license suspensions across all 35 global market jurisdictions.
- Reduced regulatory consulting and contractor spend by $480,000 annually.
Capabilities this relies on
- document intelligence
- system connectors
- risk scoring
- policy compliance
- alert routing
- evidence audit trail
Related catalog agents
More in Parivart